Cargando…

Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis

One to six percent of patients with microscopic colitis are refractory to medical treatment. The effect of faecal microbiota transplantation (FMT) in active collagenous colitis (CC) has, to the best of our knowledge, never been reported before. Here, we report the effect of repeated FMT in a patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Günaltay, Sezin, Rademacher, Lech, Hultgren Hörnquist, Elisabeth, Bohr, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323457/
https://www.ncbi.nlm.nih.gov/pubmed/28275312
http://dx.doi.org/10.3748/wjg.v23.i7.1319
_version_ 1782510025884827648
author Günaltay, Sezin
Rademacher, Lech
Hultgren Hörnquist, Elisabeth
Bohr, Johan
author_facet Günaltay, Sezin
Rademacher, Lech
Hultgren Hörnquist, Elisabeth
Bohr, Johan
author_sort Günaltay, Sezin
collection PubMed
description One to six percent of patients with microscopic colitis are refractory to medical treatment. The effect of faecal microbiota transplantation (FMT) in active collagenous colitis (CC) has, to the best of our knowledge, never been reported before. Here, we report the effect of repeated FMT in a patient with CC. The patient presented with severe symptoms including profuse diarrhea and profound weight loss. Although she responded to budesonide in the beginning, she became gradually refractory to medical treatment, and was therefore treated with FMT. The patient remained in remission for 11 mo after the third faecal transplantation. The immunomodulatory effect of the therapy was evaluated using flow cytometry, which showed alterations in the profile of intraepithelial and lamina propria lymphocyte subsets after the second transplantation. Our observations indicate that FMT can have an effect in CC, which support the hypothesis that luminal factors, influencing the intestinal microbiota, are involved in the pathogenesis of CC.
format Online
Article
Text
id pubmed-5323457
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-53234572017-03-08 Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis Günaltay, Sezin Rademacher, Lech Hultgren Hörnquist, Elisabeth Bohr, Johan World J Gastroenterol Case Report One to six percent of patients with microscopic colitis are refractory to medical treatment. The effect of faecal microbiota transplantation (FMT) in active collagenous colitis (CC) has, to the best of our knowledge, never been reported before. Here, we report the effect of repeated FMT in a patient with CC. The patient presented with severe symptoms including profuse diarrhea and profound weight loss. Although she responded to budesonide in the beginning, she became gradually refractory to medical treatment, and was therefore treated with FMT. The patient remained in remission for 11 mo after the third faecal transplantation. The immunomodulatory effect of the therapy was evaluated using flow cytometry, which showed alterations in the profile of intraepithelial and lamina propria lymphocyte subsets after the second transplantation. Our observations indicate that FMT can have an effect in CC, which support the hypothesis that luminal factors, influencing the intestinal microbiota, are involved in the pathogenesis of CC. Baishideng Publishing Group Inc 2017-02-21 2017-02-21 /pmc/articles/PMC5323457/ /pubmed/28275312 http://dx.doi.org/10.3748/wjg.v23.i7.1319 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Case Report
Günaltay, Sezin
Rademacher, Lech
Hultgren Hörnquist, Elisabeth
Bohr, Johan
Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis
title Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis
title_full Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis
title_fullStr Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis
title_full_unstemmed Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis
title_short Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis
title_sort clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323457/
https://www.ncbi.nlm.nih.gov/pubmed/28275312
http://dx.doi.org/10.3748/wjg.v23.i7.1319
work_keys_str_mv AT gunaltaysezin clinicalandimmunologiceffectsoffaecalmicrobiotatransplantationinapatientwithcollagenouscolitis
AT rademacherlech clinicalandimmunologiceffectsoffaecalmicrobiotatransplantationinapatientwithcollagenouscolitis
AT hultgrenhornquistelisabeth clinicalandimmunologiceffectsoffaecalmicrobiotatransplantationinapatientwithcollagenouscolitis
AT bohrjohan clinicalandimmunologiceffectsoffaecalmicrobiotatransplantationinapatientwithcollagenouscolitis